Titre : | Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications (2011) |
Auteurs : | S. MINNES ; A. LANG ; L. SINGER |
Type de document : | Article : Périodique |
Dans : | Addiction Science and Clinical Practice (Vol.6, n°1, July 2011) |
Article en page(s) : | 57-70 |
Langues: | Anglais |
Discipline : | PAT (Pathologie organique / Organic pathology) |
Mots-clés : |
Thésaurus mots-clés TABAC ; MEDICAMENTS ; STIMULANTS ; CANNABIS ; OPIACES ; GROSSESSE ; FOETUS ; TRAITEMENT ; MERE ; SYSTEME NERVEUX CENTRAL ; NEUROLOGIE ; EFFET SECONDAIRE ; RECOMMANDATION ; COCAINE ; NOUVEAU-NE ; DEVELOPPEMENT ; ENFANT |
Résumé : | Abuse of drugs by pregnant women both in the United States and worldwide has raised many questions regarding the effects of prenatal drug exposure on the developing fetus and subsequent child outcomes. Studies using the neurobehavioral teratology model have been undertaken to determine specific prenatal drug effects on cognitive and behavioral development. Here we summarize the findings of studies that have investigated the developmental effects of prenatal exposure to tobacco, marijuana, stimulants, and opiates. These studies consider the timing and amount of prenatal exposure; other drug exposures; maternal characteristics; and other health, nutritional, and environmental factors. We review treatment options for pregnant, substance-dependent women and therapeutic interventions for exposed children. |
Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs ; Tabac / Tobacco / e-cigarette |
Sous-type de document : | Revue de la littérature / Literature review |
Affiliation : | Mandel School of Applied Social Sciences Case, Western Reserve University, Cleveland, Ohio, USA |
Lien : | http://www.drugabuse.gov/ascp/vol6no1.html |
Accueil